Compare Global E Online Ltd (GLBE) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global E Online Ltd vs Novartis AG — how do they compare? Global E Online Ltd trades at $38.26 (market cap $6.55B), while Novartis AG trades at $152.73 (market cap $287.66B). The key difference: Novartis AG is far larger — about 43.9× Global E Online Ltd's market cap, and Novartis AG pays a 3.14% dividend while Global E Online Ltd pays none. Which is the better fit depends on your goals.
| GLBE | NVS | |
|---|---|---|
Market Cap | $6.55B | $287.66B |
Sector | Technology | Health |
52-Week High | $41.59 | $168.62 |
52-Week Low | $27.54 | $113.50 |
Enterprise Value | $6.02B | $327.68B |
Dividend Yield | — | 3.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLBE trades at $38.43, down 0.84% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 results with 33% revenue growth and raised its full-year outlook. Recent acquisition of Passport aims to enhance logistics capabilities. Valuation ratios are elevated with a P/E of 58.18, reflecting high growth expectations.
Outlook remains positive driven by merchant expansion and cross-border e-commerce growth, but high valuation poses a risk if growth slows. Analyst consensus is unanimously bullish with a $38 price target, though recent insider sales and mixed quarterly EPS performance warrant monitoring.
NVS trades at $152.51, up 1.43% today, with a bearish technical signal despite strong profitability metrics including a 75.38% gross margin and 35.21% ROE. Recent earnings show mixed results, missing Q1 2026 estimates but beating Q4 2025. The company is actively expanding its oncology pipeline through acquisitions like Myricx Bio for up to $1.5 billion (Reuters, 2026-07-06).
The outlook is balanced; robust cash flow and high margins support growth, but rising debt-to-asset ratios and cautious analyst consensus (68% hold) indicate near-term headwinds. Key risks include execution of pipeline developments and competitive pressures in pharmaceuticals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global E Online Ltd
Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
